Access to medications is a vital aspect of maintaining healthy lives, and the urge to invest in personal health has only grown since the COVID-19 pandemic.
Earlier this year, Bayer formed a new business unit that promised to shake up the consumer health category with a new personalised approach driven by digital technologies.
Personalised and precision health is a firmly established concept in the development of new prescription medicines, but not so much in the consumer health category.
A judge in the US has approved the sale of Purdue Pharma’s consumer health business Avrio, part of the bankruptcy proceedings related to the drugmaker’s proposed $10 billi
Johnson & Johnson’s consumer health unit Kenvue looks set to raise $3.8 billion in an upsized initial public offering (IPO), valuing the business at around $41 billion
Trusted Johnson & Johnson brands including Tylenol, Aveeno, Neutrogena, Listerine, and Band-Aid are set to fall under the new, independent company name in a next-chapter move of repurpo
Cancer Research UK (CRUK) has said it will award £123 million ($150 million) in funding over the next seven years to Scotland’s Beatson Institute, which will be renamed th
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho